We are live on ! Find out more
PRTA icon

Prothena Corp

132 hedge funds and large institutions have $531M invested in Prothena Corp in 2014 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 50 increasing their positions, 18 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 18

56% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 25

23% more call options, than puts

Call options by funds: $6.79M | Put options by funds: $5.51M

12% more funds holding

Funds holding: 118132 (+14)

36% less capital invested

Capital invested by funds: $832M → $531M (-$301M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
132
Holders Change
+14
Holders Change %
+11.86%
% of All Funds
3.79%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
39
Increased
50
Reduced
18
Closed
25
Calls
$6.79M
Puts
$5.51M
Net Calls
+$1.29M
Net Calls Change
+$1.8M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$66.2M +$17M +680,600 +30%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$62.1M -$28.2M -1,128,289 -29%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$53.3M +$18.4M +737,613 +45%
Bank of America
4
Bank of America
North Carolina
$37.3M +$41.2M +1,649,241 +24,243%
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$23.9M +$13.7M +548,890 +107%
Capital World Investors
6
Capital World Investors
California
$22.8M +$4.62M +184,859 +22%
State Street
7
State Street
Massachusetts
$20.3M +$17M +680,869 +312%
Jennison Associates
8
Jennison Associates
New York
$19.7M +$2.6M +104,060 +14%
BFA
9
BlackRock Fund Advisors
California
$18.1M +$3.45M +137,972 +21%
Millennium Management
10
Millennium Management
New York
$15.6M -$1.27M -50,954 -7%
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$12.4M -$6.67M -266,757 -33%
PAI
12
Palo Alto Investors
California
$12M +$27.5K +1,100 +0.2%
Norges Bank
13
Norges Bank
Norway
$11.3M +$6.14M +245,561 +97%
PA
14
Perceptive Advisors
New York
$10.9M +$3.33M +133,162 +38%
TCIM
15
TIAA CREF Investment Management
New York
$9.1M +$8.48M +339,222 +527%
RG
16
Redmile Group
California
$8.36M -$4.73M -189,091 -34%
Vanguard Group
17
Vanguard Group
Pennsylvania
$8.05M +$2.86M +114,459 +47%
TC
18
TFS Capital
Pennsylvania
$6.95M +$7.16M +286,150 +1,288%
JHIU
19
Janus Henderson Investors US
Colorado
$6.73M +$7.46M +298,456 New
BIT
20
BlackRock Institutional Trust
California
$6.42M +$2.78M +111,315 +64%
NI
21
Numeric Investors
Massachusetts
$5.63M +$6.24M +249,722 New
GC
22
Guggenheim Capital
Illinois
$5.48M -$554K -22,164 -8%
Alyeska Investment Group
23
Alyeska Investment Group
Illinois
$5.3M +$5.88M +235,000 New
TA
24
Teachers Advisors
New York
$4.29M +$4.23M +169,304 +818%
BIM
25
Bogle Investment Management
Massachusetts
$4.17M +$4.63M +185,008 New

PRTA Hedge Fund Activity: Q2 2014 in Review

132 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Prothena Corp (PRTA) for Q2 2014, worth a combined $531M — down 36% from $832M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new PRTA positions and 25 closed out — a net gain of 14 holders — while 50 added to existing stakes and 18 trimmed.

The largest buyer was Bank of America, adding an estimated $41.2M. The largest seller was OrbiMed, exiting entirely with an estimated $72.4M sold.

  • 132 institutional investors held Prothena Corp (PRTA) as of Q2 2014, up from 118 in Q1 2014.
  • Funds reported $531M of Prothena Corp stock for Q2 2014, down 36% quarter-over-quarter.
  • 39 funds opened new Prothena Corp positions in Q2 2014 and 25 closed out, a net change of +14 holders.
  • The largest Prothena Corp buyer in Q2 2014 was Bank of America, an estimated $41.2M added.
  • The largest Prothena Corp seller in Q2 2014 was OrbiMed, an estimated $72.4M sold.

Based on aggregated 13F filings for Q2 2014.